JPY5,477.00
0.31% yesterday
Tokyo, Aug 19, 08:15 am CET
ISIN
JP3301100008
Symbol
4967

Kobayashi Pharmaceutical Stock price

JPY5,476.00
+296.00 5.71% 1M
-211.00 3.71% 6M
-754.00 12.10% YTD
+82.00 1.52% 1Y
-2,854.00 34.26% 3Y
-3,854.00 41.31% 5Y
+676.00 14.08% 10Y
+3,811.00 228.89% 20Y
Tokyo, Closing price Tue, Aug 19 2025
+16.00 0.29%
ISIN
JP3301100008
Symbol
4967

Key metrics

Basic
Market capitalization
JPY402.7b
Enterprise Value
JPY333.8b
Net debt
positive
Cash
JPY69.7b
Shares outstanding
74.3m
Valuation (TTM | estimate)
P/E
34.4 | 30.1
P/S
2.5 | 2.3
EV/Sales
2.1 | 1.9
EV/FCF
35.8
P/B
1.9
Dividends
DPS
JPY104.00
Yield 1Y | 5Y
1.9% | 1.3%
Growth 1Y | 5Y
2.0% | 6.2%
Payout 1Y | 3Y
75.3% | 44.2%
Increased
8 Years
Financials (TTM | estimate)
Revenue
JPY161.5b | JPY172.2b
EBITDA
JPY30.5b | JPY26.1b
EBIT
JPY22.0b | -
Net Income
JPY11.8b | JPY13.5b
Free Cash Flow
JPY9.3b
Growth (TTM | estimate)
Revenue
-6.6% | 4.0%
EBITDA
-4.5% | -12.0%
EBIT
-11.3% | -
Net Income
-15.2% | 33.8%
Free Cash Flow
186.0%
Margin (TTM | estimate)
Gross
51.4%
EBITDA
18.9% | 15.2%
EBIT
13.7%
Net
7.3% | 7.8%
Free Cash Flow
5.8%
Financial Health
Equity Ratio
80.4%
Return on Equity
4.7%
ROCE
10.3%
ROIC
11.0%
Debt/Equity
0.0
More
EPS
JPY158.7
FCF per Share
JPY125.2
Short interest
-
Employees
4k
Rev per Employee
JPY45.8m
Show more

Is Kobayashi Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Kobayashi Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Kobayashi Pharmaceutical forecast:

5x Buy
42%
7x Hold
58%

Analyst Opinions

12 Analysts have issued a Kobayashi Pharmaceutical forecast:

Buy
42%
Hold
58%

Financial data from Kobayashi Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
161,482 161,482
7% 7%
100%
- Direct Costs 78,491 78,491
0% 0%
49%
82,991 82,991
12% 12%
51%
- Selling and Administrative Expenses 60,953 60,953
13% 13%
38%
- Research and Development Expense - -
-
-
30,516 30,516
5% 5%
19%
- Depreciation and Amortization 8,479 8,479
19% 19%
5%
EBIT (Operating Income) EBIT 22,037 22,037
11% 11%
14%
Net Profit 11,798 11,798
15% 15%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Kobayashi Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Head office Japan
CEO Norikaz Toyoda
Employees 3,615
Founded 1886
Website www.kobayashi.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today